Targeting ALS with Synergistic Combinations of Therapies

RARECast - Ein Podcast von RARECast - Donnerstags

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Kategorien:

Alon Ben-Noon, CEO of NeuroSense Therapeutic’s, discusses the company's approach to developing therapies using synergistic combinations of existing drugs, its current lead therapeutic candidate, and its efforts to target other neurodegenerative conditions beyond ALS.

Visit the podcast's native language site